A Pilot Trial of Curcumin Effects on Cognition in Schizophrenia (CRC)
Sponsor: Yale University
Terminated
Recruitment was not achieved as expected
Other terminated trials from Yale University
Other Schizoaffective Disorder trials with similar outcome
A NA clinical study on Schizoaffective Disorder and Schizophrenia, this trial is terminated or withdrawn. The trial is conducted by Yale University and has accumulated 7 data snapshots since 2016. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2018 — Jun 2018 [monthly]
Terminated NA
Status: Recruiting → Terminated
▶ Show 2 earlier versions
-
Jul 2017 — Feb 2018 [monthly]
Recruiting NA
Phase: PHASE2 → NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting PHASE2
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .